News-Medical.Net on MSN
Trial finds no benefit of anti-inflammatory therapy in trachomatous trichiasis surgery
John Kempen, MD, MPH, PhD, MHS, Director of Epidemiology for Ophthalmology at Mass Eye and Ear and Harvard Medical School, is ...
Clinical Trials Arena on MSN
Marea reports positive phase I results for MAR002 trial in acromegaly
Single-ascending doses of MAR002 showed a favourable tolerability and safety profile with no drug-related safety signals ...
John Kempen, MD, MPH, PhD, MHS , Director of Epidemiology for Ophthalmology at Mass Eye and Ear and Harvard Medical School, is the lead author of a ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Introduction Each year, millions of people experience recurrent diverticulitis episodes. Elective sigmoid colon resection reduces the risk of recurrence, but The American Society of Colon and Rectal ...
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback